DOD – Rare Cancers Research Program Resource and Community Development Award – Full Application
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with unit
Memorial Deadline: Monday 16th, September 2024
External Deadline: Monday 23rd, September 2024
Description
A recent report from the American Cancer Society (ACS) found that one in five cancers diagnosed in the United States (U.S.) is a rare cancer, which is defined as an incidence of fewer than six cases per 100,000 people per year. By this definition, around 200 forms of rare cancer compose around 20%-25% of all U.S. cancer diagnoses, which affect more than 400,000 Americans per year.
There are a significant number of incidences of rare cancers in the U.S. military population. Over 60 forms of cancer disproportionately impact those who have served in the military, and 67% of them are rare cancers. 2017 data suggests that there are approximately 8,000 new cases of rare cancers in the U.S. Department of Veterans Affairs (VA) per year which account for 16% of all VA cancers.
The Rare Cancers Research Program (RCRP) released the following funding opportunity:
- Resource and Community Development Award
- The FY24 RCRP RCDA supports the development of clinical or preclinical data sets and
research resources that advance the field of rare cancers research and ultimately improve
outcomes for individuals with rare cancers. Major gaps in patient care of rare cancers include
lack of communication and dissemination strategies for rare cancers research and clinical
findings within communities; lack of therapeutics and mechanistic studies to inform treatment
development; lack of research and clinical resources, including patient tissues, cell, and tumor
models; and lack of infrastructure for sharing data and other resources.
The intent of this funding opportunity is to develop research platforms that can share resources and
knowledge pertaining to available preclinical or clinical research models, molecular pathways, and
therapeutic approaches to facilitate collaboration and information sharing among stakeholders such
as researchers, patients, caregivers, clinicians, and other members of the rare cancers community.
To view the funding opportunity announcement and submit a pre-application visit https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=587103
Pre-Application (Preproposal) Submission Deadline: 5:00 p.m. Eastern time (ET),
June 17, 2024
Application Submission Deadline: 11:59 p.m. ET, September 23, 2024